541-323-3833Human papilloma virus (HPV) infection impacts response to treatment for head and neck cancer, Georgetown researchers find.
Previous studies have found that head and neck cancer patients have a better prognosis if they are positive for the HPV virus. In new research, HPV status also guided treatment choices. Patients with HPV-positive head and neck cancer responded better to treatment with Cetuximab and radiation therapy than did those who did not have the virus. Read the full story here.